/주식/AUTL
AUTL

AUTL

USD

Autolus Therapeutics plc American Depositary Share

$1.410-0.110 (-7.237%)

실시간 가격

Healthcare
생명공학
영국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.520

고가

$1.535

저가

$1.400

거래량

2.28M

기업 기본 정보

시가총액

375.3M

산업

생명공학

국가

United Kingdom

거래 통계

평균 거래량

3.73M

거래소

NMS

통화

USD

52주 범위

저가 $1.105현재가 $1.410고가 $4.12

관련 뉴스

Analyst Upgrades

Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.

더 보기
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
GlobeNewswire

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025

LONDON and GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation

더 보기
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
GlobeNewswire

Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025

Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for Phase 2 pivotal

더 보기
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025